Evidence for a direct antitumor mechanism of action of bovine lactoferricin

Anticancer Research

Volumn 22, Issue 5, 2002, Pages 2703-2710

  Tone Eliassen, Liv ^a   Berge, Gerd ^a   Sveinbjørnsson, Baldur ^a   Svendsen, John S ^a   Vorland, Lars H ^b   Rekdal, Øystein ^a  

^a UNIVERSITY OF TROMSØ   (Norway)

^b UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

Author keywords

Antitumor activity; Lactoferricin

Indexed keywords

LACTOFERRICIN; LACTOFERRIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; COLON CARCINOMA; CONTROLLED STUDY; CYTOLYSIS; FEMALE; FIBROSARCOMA; MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; SCANNING ELECTRON MICROSCOPY;

ANIMALS; ANTINEOPLASTIC AGENTS; CATTLE; COLONIC NEOPLASMS; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; FIBROSARCOMA; LACTOFERRIN; MELANOMA, EXPERIMENTAL; MICE; PEPTIDE FRAGMENTS;

EID: 0036765924     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Boman HG: Peptide antibiotics and their role in innate immunity. Annu Rev Immunol 13: 61-92, 1995.
2. Cohen MS, Britigan BE, French M and Bean K: Preliminary observations on lactoferrin secretion in human vaginal mucus: variation during the menstrual cycle, evidence of hormonal regulation, and implications for infection with Neisseria gonorrhoeae. Am J Obstet Gynecol 157: 1122-5, 1987.
3. Bullen JJ, Rogers HJ and Griffiths E: Role of iron in bacterial infection. Curr Top Microbiol Immunol 80: 1-35, 1978.
4. Gutteberg TJ, Dalaker K and Vorland LH: Early response in neonatal septicemia. The effect of Escherichia-coli, Streptococcus agalactiae and tumor necrosis factor on the generation of lactoferrin. AMPIS 98: 1027-32, 1990.
5. Masson P, Heremans JF, Prignot JJ and Wauters G: An ironbinding protein common to many external secretions. Clin Chim Acta 14: 735-9, 1966.
6. Gahr M, Speer CP, Damerau B and Sawatzki G: Influence of lactoferrin on the function of human polymorphonuclear leukocytes and monocytes. J Leukoc Biol 49: 427-33, 1991.
7. Horwitz DA, Bakke AC, Abo W and Nishiya K: Monocyte and NK cell cytotoxic activity in human adherent cell preparations: discriminating effects of interferon and lactoferrin. J Immunol 132: 2370-4, 1984.
8. Shau H, Kim A and Golub SH: Modulation of natural killer and lymphokine-activated killer cell cytotoxicity by lactoferrin. J Leukoc Biol 51: 343-9, 1992.
9. Masson PL, Heremans JF and Schonne E: Lactoferrin, an iron-binding protein in neutrophilic leukocytes. J Exp Med 130: 643-58, 1969.
10. Levay PF and Viljoen M: Lactoferrin: a general review. Haematologica 80: 252-67, 1995.
11. Johansson B: Isolation of an iron-containing red protein from human milk. Acta Chem Scand 14: 510-512, 1960.
12. Brock JH: Lactoferricin in human milk: its role in iron-absorption and protection against enteric infection in the new-born infant. Arch Dis Child 55: 417-421, 1980.
13. Bezault J, Bhimani R, Wiprovnick J and Furmanski P: Human lactoferrin inhibits growth of solid tumors and development of experimental metastases in mice. Cancer Res 54: 2310-2, 1994.
14. Iigo M, Kuhara T, Ushida Y, Sekine K, Moore MA and Tsuda H: Inhibitory effects of bovine lactoferrin on colon carcinoma 26 lung metastasis in mice. Clin Exp Metastasis 17: 35-40, 1999.
15. Sekine K, Watanabe E, Nakamura J, Takasuka N, Kim DJ, Asamoto M, Krutovskikh V, Baba-Toriyama H, Ota T, Moore MA, Masuda M, Sugimoto H, Nishino H, Kakizoe T and Tsuda H: Inhibition of azoxymethane-initiated colon tumor by bovine lactoferrin administration in F344 rats. Jpn J Cancer Res 88: 523-6, 1997.
16. Yoo YC, Watanabe S, Watanabe R, Hata K, Shimazaki K and Azuma I: Bovine lactoferrin and lactoferricin inhibit tumor metastasis in mice. Adv Exp Med Biol 443: 285-91, 1998.
17. Damiens E, El Yazidi l, Mazurier J, Duthille I, Spik G and Boilly-Marer Y: Lactoferrin inhibits GI cyclin-dependent kinases during growth arrest of human breast carcinoma cells. J Cell Biochem 74: 486-98, 1999.
18. Yoo YC, Watanabe R, Koike Y, Mitobe M, Shimazaki K, Watanabe S and Azuma I: Apoptosis in human leukemic cells induced by lactoferricin, a bovine milk protein-13 derived peptide: involvement of reactive oxygen species. Biochem Biophys Res Commun 237: 624-8, 1997.
19. Vorland LH, Ulvatne H, Andersen J, Haukland H, Rekdal Ø, Svendsen JS and Gutteberg TJ: Lactoferricin of bovine origin is more active than lactoferricins of human, murine and caprine origin. Scand J Infect Dis 30: 513-7, 1998.
20. Strøm M, Rekdal Ø and Svendsen JS: Structure-antibacterial activity relationships of 15-residue lactoferricin derivatives. J Pept Res 56: 265-274, 2000.
21. Rekdal Ø, Andersen J, Vorland LH and Svendsen JS: Construction and synthesis of lactoferricin derivatives with enhanced antibacterial activity. J Peptide Sci 5: 32-45, 1999.
22. Bellamy W, Takase M, Yamauchi K, Wakabayashi H, Kawase K and Tomita M: Identification of the bactericidal domain of lactoferrin. Biochim Biophys Acta 1121: 130-6, 1992.
23. Seljelid R: A water-soluble aminated beta 1-3D-glucan derivative causes regression of solid tumors in mice. Biosci Rep 6: 845-51, 1986.
24. Markovic SN and Murasko DM: Neoadjuvant immunotherapy with interferon of the spontaneously metastasizing murine B16FIOL melanoma. Int J Cancer 45: 788-94, 1990.
25. Corbett TH, Griswold DP, Jr., Roberts BJ, Peckham JC and Schabel FM, Jr: Tumor induction relationships in development of transplantable cancers of the colon in mice for chemotherapy assays, with a note on carcinogen structure. Cancer Res 35: 2434-9, 1975.
26. Mosmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55-63, 1983.
27. Bozzola JJ and Russel LD: Specimen preparation for scanning electron microscopy. In: Electron Microscopy (Bozzola JJ, Russel LD, Eds.) Sudbury, NLA, 01776, Jones and Barlett Publicshers. 1992, pp 41-63.
28. Connor J, Bucana C, Fidler IJ and Schroit AJ: Differentiation-dependent expression of phosphatidylserine in mammalian plasma membranes: quantitative assessment of outer leaflet lipid by prothrombinase complex formation. Proc Natl Acad Sci USA 86: 3184-8, 1989.
29. Utsugi T, Schroit AJ, Connor J, Bucana CD and Fidler IJ: Elevated expression of phosphatidylserine in the outer membrane leaflet of human tumor cells and recognition by activated human blood monocytes. Cancer Res 51: 3 062-6, 1991.
30. Matsuzaki K, Sugishita K, Fujii N and Miyajima K: Molecular basis for membrane selectivity of an antimicrobial peptide, magainin 2. Biochemistry 34: 3423-9, 1995.
31. Yamauchi K, Tomita M, Giehl TJ and Ellison RTd: Antibacterial activity of lactoferrin and a pepsin-derived lactoferrin peptide fragment. Infect Immun 61: 719-28, 1993.
32. Moore SA, Anderson BF, Groom CR, Haridas M and Baker EN: Three-dimensional structure of diferric bovine lactoferrin at 2.8 A resolution. J Mol Biol 274: 222-36, 1997.
33. Epand RM and Vogel HJ: Diversity of antimicrobial peptides and their mechanisms of action. Biochim Biophys Acta 1462: 11-28, 1999.
34. Matsuzaki K, Harada M, Handa T, Funakoshi S, Fujii N, Yajima H and Miyajima K: Magainin 1-induced leakage of entrapped calcein out of negatively-charged lipid vesicles. Biochim Biophys Acta 981: 130-4, 1989.
35. Odell EW, Sarra R, Foxworthy M, Chapple DS and Evans RW: Antibacterial activity of peptides homologous to a loop region in human lactoferrin. FEBS Lett 382: 175-8, 1996.
36. Schibli DJ, Hwang PM and Vogel HJ: The structure of the antimicrobial active center of lactoferricin B bound to sodium dodecyl sulfate micelles. FEBS Lett 446: 213-7, 1999.
37. Strom MB, Rekdal O, Stensen W and Svendsen JS: Increased antibacterial activity of 15-residue murine lactoferricin derivatives. J Pept Res 57: 127-139, 2001.